[Member Post]

 

Listen here: https://www.angelinvestboston.com/tim-spong-vistapath-bio A terrible error in a lab led Tim Spong to start a company to improve the reliability and efficiency of pathology labs; big industry players are noticing. This interview was part of my due diligence on Tim’s startup, VistaPath Bio. Subsequently, I invested in the company. Highlights include: Sal Daher Introduces Tim […]

⚠️ This is a members-only post on Ricochet's Member Feed. Want to read it? Join Ricochet's community of conservatives and be part of the conversation.

Join Ricochet for free.


There are 6 comments.
But you can't read them because you're not signed in!

Become a member to read the comments and join the conversation. Or sign in if you're already a member.
Become a member to read the comments and join the conversation. Or sign in if you're already a member.